Pregnancy is the most important period in women"s life but it can be dangerous also. Pregnancy is a physiological state with increased alteration in biochemical and mechanical processes, if there are no pregnancy complications during pregnancy, these changes will reversible soon after delivery. 1 Hypertension and proteinuria are the important complications of pregnancy and are associated with high maternal and perinatal mortality and morbidity. 2 "Berg and colleagues reported that 16%, 3201 of maternal death in US from 1991-1997 were complications of pregnancy induced hypertension. During this study black race had 3% higher mortality vasospasm and endothelial dysfunction plays an important role in development of GHT, but pathophysiology remains unknown. 3,4 According to several studies change in beta HCG and lipid profile seems to be important in the pathogenesis of GHT. Measurement of beta HCG and lipid parameters
Background:The fever during pregnancy is the omnious sign. Early detection and prompt management of fever prevents maternal mortality and morbidity. Any maternal hyperthermia (>38.9°C) potentially affect the fetus. Hence study was conducted to know the outcome of fever in pregnancy. Methods: To study the outcome of pregnant women admitted with fever in obstetrics ward at MGMGH, Trichy over the period of 6 months from July 2017 to December 2017. Results: The incidence of fever was 6%. In this study the most common cause was viral fever among which dengue fever was most common. Hence outcome depends on its impact on pregnant mother and fetus. Many preterm labour (24%) were noted in this study which needs NICU admission of babies. Maternal mortality was 25%, most of it were associated with DIC, IUD and one or two combined risk factors. Conclusions: The incidence of fever was 6%. In this study the most common cause was viral fever among which dengue fever was most common. Hence outcome depends on its impact on pregnant mother and fetus. Many preterm labour (24%) were noted in this study which needs NICU admission of babies. Maternal mortality was 25%, most of it were associated with DIC, IUD and one or two combined risk factors.
Background: Caesarean section (CS) rates continue to increase worldwide, particularly in middle and high-income countries without evidence indicating substantial maternal and perinatal benefits from the increase and some studies showing negative consequences for maternal and neonatal health. The objective of this study is to analyse the repeat caesarean section rates in a tertiary centre.Methods: This is a retrospective study carried out in the Department of Obstetrics and Gynaecology, Pudhukottai Medical College, Tamil Nadu, India for a 12-month period from January 2017 to December 2017 with the aim to analyse the rate and indications for caesarean section and to identify the measures to decrease its incidence if possible. A total of 2654 cesarean deliveries were conducted in one year, out of which 1380 (51.99%) were primary cesarean sections and 1274(48%) were repeat cesarean sections.Results: Repeat LSCS is more common in age group of 21-30 years (80%) and in second gravida (90.42%). The incidence of caesarean section is 94.6%. Patients who had successful trial of scar were 73. In all these patients, measures were taken to shorten the 2nd stage of labour either by giving episiotomy alone or by application of outlet forceps or vacuum. Out of these 62 (84.9%) patients were delivered by episiotomy alone.Conclusions: Caesarean section has become one of the commonly performed surgeries in obstetric practice. Implementation of standard labour management strategies can reduce primary caesarean section rate without compromising maternal and fetal safety. One important strategy is ROBSON ‘S 10 GROUP classification system for caesarean section needs to be adopted. Targets of care needs to be set up which also depends on the available resources and expertise. With continuous critical review as described and frequent comparison with other delivery units, the caesarean section rate in each individual unit can be reduced to an appropriate level.
Background: The objective is to study the fetomaternal outcome in teenage pregnancy at MGMGH for the study period of 6 months from April 2018 to September 2018. Teenage pregnancy is a worldwide health problem. WHO defined adolescence as the period from 10-19 years. It is a serious health problem in a developing country like India. Teenage pregnancy is associated with high risk of prematurity, low birthweight, preeclampsia and anaemia. The NHFS IV 2015 -2016 estimates that overall teenage pregnancy in India 7.9%.Methods: It is a retrospective study conducted in a tertiary care hospital at MGMGH, Trichy over a period of 6 months.251 teenage pregnant women delivered at our institution were selected for the study out of 4508 total deliveries during the study period. Parameters including incidence, age, parity, booking status, educational and socioeconomic status, medical disorders, antepartum, intrapartum, postpartum complications, mode of delivery and neonatal outcome were studied.Results: Study showed the incidence of teenage pregnancy at our MGMGH is 5.56%. Among these teenage pregnant women 47.1% had anaemia, 23.1% had gestational hypertension,4.8% of women had eclampsia, 22.3% % had preterm delivery. Lscs rate was 27.1%,70.29 % had Normal vaginal delivery,1.6% had instrumental deliveries, 31.5% had low birth weight babies,28.2 % NICU admissions, 2.9% perinatal deaths.Conclusions: Teenage pregnancy is associated with increased incidence of anaemia, pre-eclampsia, eclampsia, preterm delivery, instrumental delivery, low birth weight and perinatal death. By improving socio economic status, education, nutrition, good antenatal care, public awareness, institutional delivery and postnatal care help in reducing maternal and perinatal morbidity and mortality in adolescent pregnancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.